Cargando…

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, insulin resistance and a systemic pro-inflammatory response. Here we show that tumour necrosis factor receptor-associated factor 3 (TRAF3) is upregulated in mouse and human livers with hepatic steatosis. After 24 weeks...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pi-Xiao, Zhang, Xiao-Jing, Luo, Pengcheng, Jiang, Xi, Zhang, Peng, Guo, Junhong, Zhao, Guang-Nian, Zhu, Xueyong, Zhang, Yan, Yang, Sijun, Li, Hongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/ https://www.ncbi.nlm.nih.gov/pubmed/26882989 http://dx.doi.org/10.1038/ncomms10592

Ejemplares similares

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
por: Ji, Yan-Xiao, et al.
Publicado: (2016)

Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3
por: Zhang, Jiazhen, et al.
Publicado: (2017)

TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice
por: Tang, Minghui, et al.
Publicado: (2008)

TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis
por: Wang, Weijun, et al.
Publicado: (2021)

Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
por: Chen, Zheng, et al.
Publicado: (2015)

Tert-Butylhydroquinone alleviates insulin resistance and liver steatosis in diabetes
por: Zhu, Tian-tian, et al.
Publicado: (2022)

(+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation
por: Chiou, Wen-Fei, et al.
Publicado: (2014)

Activity of Pterostilbene Metabolites against Liver Steatosis in Cultured Hepatocytes
por: Trepiana, Jenifer, et al.
Publicado: (2020)

Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis
por: Daugherty, Alan, et al.
Publicado: (2019)

Roles of the Kinase TAK1 in TRAF6-Dependent Signaling by CD40 and Its Oncogenic Viral Mimic, LMP1
por: Arcipowski, Kelly M., et al.
Publicado: (2012)

Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin Resistance
por: Kang, Hong Soon, et al.
Publicado: (2011)

TRAF6 Promotes Myogenic Differentiation via the TAK1/p38 Mitogen-Activated Protein Kinase and Akt Pathways
por: Xiao, Fang, et al.
Publicado: (2012)

Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway
por: Liao, Hai-han, et al.
Publicado: (2019)

The Effect and Mechanism of Tamoxifen-Induced Hepatocyte Steatosis in Vitro
por: Zhao, Fei, et al.
Publicado: (2014)

Alterations in the hepatocyte epigenetic landscape in steatosis
por: Maji, Ranjan Kumar, et al.
Publicado: (2023)

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
por: Wang, Huan, et al.
Publicado: (2023)

Primary Broiler Hepatocytes for Establishment of a Steatosis Model
por: Zhang, Cai, et al.
Publicado: (2022)

TTRAP Is a Novel Component of the Non-Canonical TRAF6-TAK1 TGF-β Signaling Pathway
por: Várady, György, et al.
Publicado: (2011)

TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling
por: Espada, Constanza E., et al.
Publicado: (2021)

TRAF3 mediates neuronal apoptosis in early brain injury following subarachnoid hemorrhage via targeting TAK1-dependent MAPKs and NF-κB pathways
por: Zhou, Yan, et al.
Publicado: (2021)

Retinoic Acid Receptor β Loss in Hepatocytes Increases Steatosis and Elevates the Integrated Stress Response in Alcohol-Associated Liver Disease
por: Melis, Marta, et al.
Publicado: (2023)

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan
por: SAWANO, TAKEYUKI, et al.
Publicado: (2015)

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver
por: Zhang, Yuehui, et al.
Publicado: (2018)

Study of Valproic Acid-Enhanced Hepatocyte Steatosis
por: Chang, Renin, et al.
Publicado: (2016)

NUMBL Interacts with TAK1, TRAF6 and NEMO to Negatively Regulate NF-κB Signaling During Osteoclastogenesis
por: Swarnkar, Gaurav, et al.
Publicado: (2017)

Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α
por: Ren, Huihui, et al.
Publicado: (2021)

TRAF2 decreases lipid accumulation in hepatocytes under endoplasmic reticulum stress: TRAF2 increases the ubiquitination of XBP1s
por: Li, Siqi, et al.
Publicado: (2023)

The p66shc-mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
por: Zhang, Jing, et al.
Publicado: (2020)

CARD3 Promotes Cerebral Ischemia‐Reperfusion Injury Via Activation of TAK1
por: Wu, Xiaolin, et al.
Publicado: (2020)

Knockdown of hepatocyte Perilipin-3 mitigates hepatic steatosis and steatohepatitis caused by hepatocyte CGI-58 deletion in mice
por: Bao, Xinyu, et al.
Publicado: (2022)

The relationship between TRAF6 and tumors
por: Li, Jiaoduan, et al.
Publicado: (2020)

Distinct roles of TRAF6 and TAK1 in the regulation of adipocyte survival, thermogenesis program, and high-fat diet-induced obesity
por: Gallot, Yann S., et al.
Publicado: (2017)

TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex
por: Luo, Chen, et al.
Publicado: (2017)

USP7 Inhibits Osteoclastogenesis via Dual Effects of Attenuating TRAF6/TAK1 Axis and Stimulating STING Signaling
por: Xie, Ziang, et al.
Publicado: (2023)

Steatosis is a Lot More than Holes in Hepatocytes
por: Chakrabarti, Subrata
Publicado: (2009)

Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes
por: Trepiana, Jenifer, et al.
Publicado: (2020)

Erratum: The p66shc-Mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
por: Zhang, Jing, et al.
Publicado: (2020)

Overexpression of miR-146b-5p Ameliorates Neonatal Hypoxic Ischemic Encephalopathy by Inhibiting IRAK1/TRAF6/TAK1/NF-αB Signaling
por: Yang, Guang, et al.
Publicado: (2020)

TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis
por: Seki, Ekihiro
Publicado: (2014)

Macrophage Notch1 inhibits TAK1 function and RIPK3-mediated hepatocyte necroptosis through activation of β-catenin signaling in liver ischemia and reperfusion injury
por: Xu, Dongwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mejikplrl1dre45vo0j0ovvdph